- Clinical characteristics and outcomes in diffuse large B cell lymphoma patients aged 70 years and older: a single-center experience with a literature review
-
Jung YH, Woo IS, Han CW
- KMID: 2381567
- Korean J Intern Med.
- 2015 Sep;30(5):684-693.
- doi: 10.3904/kjim.2015.30.5.684
BACKGROUND/AIMS: Among diffuse large B cell lymphoma (DLBCL) patients, determining the appropriate dose and chemotherapy schedule to balance toxicity and efficacy is harder in elderly than in younger patients. Moreover,... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial Chemoembolization Using Gelatin Sponges or Microspheres Plus Lipiodol-Doxorubicin versus Doxorubicin-Loaded Beads for the Treatment of Hepatocellular Carcinoma
-
Liu YS, Ou MC, Tsai YS, Lin XZ, Wang CK, Tsai HM, Chuang MT
- KMID: 2069990
- Korean J Radiol.
- 2015 Feb;16(1):125-132.
- doi: 10.3348/kjr.2015.16.1.125
OBJECTIVE: To retrospectively compare treatment of hepatocellular carcinoma (HCC) with transarterial chemoembolization (TACE) using gelatin sponges or microspheres plus lipiodol-doxorubicin vs. doxorubicin-loaded drug-eluting beads (DEB). MATERIALS AND METHODS: A total of... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal technique and response of doxorubicin beads in hepatocellular cancer: bead size and dose
-
Martin R, Irurzun J, Munchart J, Trofimov I, Scupchenko A, Tatum C, Narayanan
- KMID: 1105514
- Korean J Hepatol.
- 2011 Mar;17(1):51-60.
- doi: 10.3350/kjhep.2011.17.1.51
BACKGROUND/AIMS: It has been shown that the drug-eluting beads loaded with doxorubicin (DEBDOX) are effective for the treatment of hepatocellular carcinoma (HCC). However, the optimal safety and efficacy still remain... -
- CITED
-
- Close
- SHARE
-
- Close
